$LGN

Legence (LGN) Q2 2026 Earnings Call Transcript

Legence (LGN) reported Q2 2026 revenue of $1.3B, up 110.7% year over year, driven by the Bowers Group acquisition and data center demand. Adjusted EBITDA rose to $154.6M, margin 12.2%. Backlog and awards were $5.7B. The company raised Q3 and full-year 2026 guidance, including FY revenue $4.7B-$4.8B and adjusted EBITDA $565M-$585M.

Original reporting
Published Aug 14, 2026, 12:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 12:58 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Legence (LGN) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$LGNBullishHigh
01

Why it matters

The key tradable items are the raised FY 2026 revenue and adjusted EBITDA guidance, the explicit Q3 2026 revenue and adjusted EBITDA range, and disclosed leverage reduction to 1.5, offset by margin mix headwinds and a goodwill impairment tied to softer sustainability consulting demand.

02

Market read

This is a guidance-and-backlog update with concrete quarterly and full-year ranges, plus balance-sheet and margin disclosures that can drive earnings estimate revisions.

03

What to watch

Goodwill impairment tied to mixed-use sustainability indicates underlying demand dispersion; traders should watch whether backlog quality and book-to-bill sustain without further mix deterioration.

Relevance 9/10Novelty 9/10Timing: pre-market today, after-hours guidance and Q2 results released Aug. 13

Background

Legence’s Q2 2026 call highlights record demand in data centers and technology, integration of the Bowers Group acquisition, and capacity expansion via additional fabrication square footage.

Company-level read

Ticker impact

$LGNBullishMedium confidence
Context

Legence reported Q2 2026 revenue of $1.3B, raised full-year 2026 guidance, and guided Q3 revenue to $1.225B-$1.275B.

Expected impact

Likely positive bias for LGN into the next earnings window, with volatility around margin/mix and mixed-use sustainability demand.

Evidence & confidence

The article discloses multiple fresh, decision-relevant datapoints: Q2 results, raised FY revenue and adjusted EBITDA ranges, and explicit Q3 guidance, alongside disclosed goodwill impairment and margin headwinds from segment mix.

Market effects

Data center and technology infrastructure demand appears to be accelerating, reinforcing read-through for construction services and off-site fabrication capacity constraints.

Unionized national workforce deployment and fabrication expansion to Iowa and North Carolina suggest regional execution capacity improvements.

Limited direct global macro linkage; story is primarily US data center and reshoring-driven capex execution.

Counterpoint

The raised guidance may be driven by acquisition contribution and project timing pull-ins, while sustainability consulting softness and margin mix could reassert pressure later in 2026.

Key entities

  • Legence

    Reported Q2 2026 results, raised FY 2026 guidance, and provided Q3 2026 guidance on revenue and adjusted EBITDA.

  • Jeffrey Sprau

    CEO commentary emphasized increasing momentum, larger project awards, and schedule pull-forward in data center and semiconductor markets.

  • Stephen Butz

    CFO discussed margin mix, sustainability consulting softness, goodwill impairment, and expected effective tax rate range.

Related articles

MedAI 8/10

Legence Q2 2026 slides: record revenue, backlog despite margin pressure

Legence Corp. reported Q2 2026 results on Aug. 13, citing record revenue and backlog growth tied to data center and mission-critical building systems demand. Revenue rose to $1.262B (+111% YoY) and backlog to $5.67B (+105%). Adjusted EPS was -$0.37 vs +$0.21 expected. Shares fell over 7% to $63.68; full-year guidance was raised to $4.7B-$4.8B revenue.

$LGNMedAI 8/10

Legence revenue rises 110.7% to $1.26 billion

Legence (NASDAQ:LGN) reported Q2 2026 revenue of $1.26 billion, up 110.7% year over year, and Adjusted EBITDA of $154.6 million. The company posted a net loss of $27.8 million and ended with $292 million cash and $1.03 billion debt. It raised FY2026 revenue guidance to $4.7–$4.8 billion and Adjusted EBITDA to $565–$585 million.

$LGNMed

Legence Q3 Results: Sales Guidance $1.225B

Legence (NASDAQ: LGN) guided Q3 sales to $1.225B to $1.275B, above the $1.080B analyst consensus. The low end is about $145M higher, implying roughly 13% above street expectations. No other financial metrics were provided in the source.

Med

Legence Corp. Revises Earnings Guidance for Full Year 2026

Legence Corp. revised its full-year 2026 earnings guidance, raising expected total revenues to $4.7 billion to $4.8 billion from a prior range of $4.1 billion to $4.3 billion. The company provides engineering, installation and maintenance services for mission-critical building systems, operating in Engineering & Consulting and Installation & Maintenance segments.